Press Releases - Lupus Research

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] READ MORE

The Lupus Research Alliance Awards 2021 Lupus Insight Prize to Immunologist Dr. Martin Kriegel

Research Is First to Pinpoint a Gut Organism to Lupus, Advancing Understanding of the Microbiome in Autoimmune Disease NEW YORK, NY. June 9. The Lupus Research Alliance (LRA) announced today that Martin Kriegel, MD, PhD, of the University of Münster is the 2021 Lupus Insight Prize Awardee for his cutting edge research in the understanding […] READ MORE

Former Jets Player Willie Colon Hosts NJ Event with Support from Other Pro Athletes, Raising Nearly $300,000 for Lupus Research Alliance

SUMMIT, NJ — May 3. In honor of May, Lupus Awareness Month, former Super Bowl Champion and Barstool Sports radio personality Willie Colon, hosted the annual Willie Colon Golf Outing for the Lupus Research Alliance (LRA). Dedicated to advancing lupus research, Mr. Colon is a member of the Lupus Research Alliance Board of Directors. In […] READ MORE

Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus

Dr. Eric Morand Publishes Results Funded by LRA’s Distinguished Innovator Award NEW YORK, NY. March 31, 2021. Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with glucocorticoids (steroids) effective at lower doses, lessening harmful side effects. In a study […] READ MORE

Lupus Research Alliance Announces 2020 Distinguished Innovator Awards Aimed at New Lupus Treatments

NEW YORK, March 25, 2021 — The Lupus Research Alliance proudly announces two exceptional recipients of the 2020 Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Jacques Banchereau, PhD and Ignacio Sanz, MD. Both projects funded by this grant are investigating different mechanisms altered in lupus patients that induce an autoimmune response. Their findings […] READ MORE

JDRF, Lupus Research Alliance, and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases

First Joint Common Mechanisms Grants Announced NEW YORK, NY, February 24, 2021 – JDRF International, the Lupus Research Alliance and the National Multiple Sclerosis Society joined forces to accelerate research and discovery in autoimmunity and are proud to announce the recipients of their first joint grants. Called Decoding Immune-Mediated Diseases – Novel Approaches for Therapeutic […] READ MORE

Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)

First Oral Treatment for Lupus Nephritis; Second Lupus Treatment to Receive FDA Approval in Past Month NEW YORK, NY. January 22, 2021. The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals’ LupkynisTM (voclosporin) as the first oral treatment developed specifically for […] READ MORE

LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA

NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug Administration (FDA) approval of belimumab (Benlysta®) as the first-ever treatment specifically indicated for lupus nephritis (LN) in adults. Another milestone, this new indication is the only FDA approval of a new lupus treatment since belimumab was […] READ MORE

Over Half of People with Lupus Would Take COVID-19 Vaccine, Shows LRA Survey

Updated January 4, 2021 New York, NY– December 16, 2020. More than half of people with lupus (54%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance (LRA). However, it is important to note that 24% […] READ MORE

New Survey Shows Education and Communication Gaps in Lupus Nephritis Care

1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus New York, NY– December 7, 2020. Significant gaps in education and communication among patients and physicians pose barriers to lupus nephritis (LN) care, according to results of two companion surveys conducted by the National Kidney Foundation (NKF) and the Lupus Research Alliance (LRA). Half […] READ MORE

LRA’s 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development

December 3, 2020 NEW YORK, NY. December 3 – The Lupus Research Alliance is proud to announce the 2020 recipients of its Lupus Mechanisms and Targets Award (LMTA). The highly competitive grant gives researchers up to $200,000 a year for up to three years. As indicated by the title of the award, the 2020 awardees […] READ MORE

LRA’s Lupus Research 2020 Virtual Fundraising Event Raises $3.1 Million for Science

Global Lupus Community Rallied by Lady Gaga, Selena Gomez, Norm Lewis and a Host of Inspiring Lupus Advocates New York, NY. November 24, 2020 – The Lupus Research Alliance (LRA)’s 2020 Virtual Fundraising Event surpassed its goal last night, raising $3.1 million for lupus research programs. Led by inspiring words from Lady Gaga and Selena Gomez […] READ MORE